Kerry Group (OTCMKTS:KRYAY – Get Rating) had its price objective reduced by equities researchers at JPMorgan Chase & Co. from €150.00 ($157.89) to €135.00 ($142.11) in a research report issued on Monday, The Fly reports.
A number of other research analysts have also commented on KRYAY. Barclays increased their price objective on Kerry Group from £136 ($166.59) to £137 ($167.81) in a report on Friday, April 29th. Morgan Stanley dropped their target price on Kerry Group from €127.00 ($133.68) to €122.00 ($128.42) and set an “overweight” rating on the stock in a report on Monday, April 11th. Credit Suisse Group reduced their price target on Kerry Group from €135.00 ($142.11) to €128.00 ($134.74) and set an “outperform” rating on the stock in a research report on Wednesday, April 13th. Finally, UBS Group increased their price target on Kerry Group from €115.00 ($121.05) to €120.00 ($126.32) and gave the company a “buy” rating in a research note on Friday, April 29th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $2,841.00.
Shares of KRYAY traded up $3.72 during trading on Monday, reaching $97.33. The company’s stock had a trading volume of 14,200 shares, compared to its average volume of 19,698. The company has a fifty day moving average of $103.23 and a two-hundred day moving average of $114.94. Kerry Group has a twelve month low of $92.32 and a twelve month high of $153.37. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.13 and a current ratio of 1.73.
About Kerry Group (Get Rating)
Kerry Group plc, together with its subsidiaries, develops, manufactures, and delivers taste and nutrition solutions for the food, beverage, and pharmaceutical industries in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Taste & Nutrition and Consumer Foods.